Uterine fibroid treatment
作者： Asif Syed Ahmed
DOI:
关键词:
摘要: The use of a) an angiotensin-converting enzyme (ACE) inhibitor such as Captopril or Enalapril, b) angiotensin II-receptor antagonist Saralasin Losartan, c) a renin inhibitor, Remikiren [N-(pyridyl-3-propionyl)-phenylalanyl-histidyl-(3S,4S) ACHPA-isoleucylamino]-2-methyl-2-dihydroxy-1,3-propane, for the manufacture medicament treatment uterine fibroids is disclosed. ACE may be used concomitantly sequentially with gonadotropin-releasing hormone agonist Buserelin Goserelin.
lens.org 参考文章(5)
Henry Uhlman Bryant, Jeffrey Alan Dodge, Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease ,(1998)
Mark Campbell-Boswell, Abel Lazzarini Robertson, Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro Experimental and Molecular Pathology. ,vol. 35, pp. 265- 276 ,(1981) , 10.1016/0014-4800(81)90066-6
K. Nagasawa, R. Zimmermann, B. Munkel, W. Linz, B. Scholkens, J. Schaper, Extracellular matrix deposition in hypertensive hearts. Antifibrotic effects of ramipril European Heart Journal. ,vol. 16, pp. 33- 37 ,(1995) , 10.1093/EURHEARTJ/16.SUPPL_C.33
E. R. Lumbers, N. M. Kingsford, R. I. Menzies, A. D. Stevens, Acute effects of captopril, an angiotensin-converting enzyme inhibitor, on the pregnant ewe and fetus American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 262, ,(1992) , 10.1152/AJPREGU.1992.262.5.R754
Janet K. Christiansen, The facts about fibroids. Presentation and latest management options Postgraduate Medicine. ,vol. 94, pp. 129- 137 ,(1993) , 10.1080/00325481.1993.11945710